Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • My watchlists
  • Help
  • Contact us

Renalytix plc (RENX) ORD GBP0.0025

Sell:700.00p Buy:730.00p 0 Change: 5.00p (0.70%)
FTSE AIM 100:1.32%
Market closed |  Prices as at close on 28 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:700.00p
Buy:730.00p
Change: 5.00p (0.70%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 28 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:700.00p
Buy:730.00p
Change: 5.00p (0.70%)
Market closed |  Prices as at close on 28 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Renalytix plc, formerly Renalytix AI plc, is an artificial intelligence-enabled in vitro diagnostics company. The Company's diagnostic platform, KidneyIntelX, employs artificial intelligence-enabled algorithm that combines data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record (HER) systems, to generate a patient risk score. Its patient risk score enables prediction of progressive kidney function decline in chronic kidney disease (CKD), allowing physicians and healthcare systems to manage the allocation of treatments and clinical resources to patients. KidneyIntelX provides a reportable patient risk score integrated with specific guideline-driven clinical recommendations designed to manage patient treatment and compliance outcomes. The KidneyIntelX risk score is tied to specific clinical guideline recommendations developed by the healthcare system, health insurance providers or practice groups.

Contact details

Address:
Avon Hse, 19 Stanwell Road
PENARTH
CF64 2EZ
United Kingdom
Telephone:
+44 (020) 79338780
Website:
https://renalytixai.com/

Important dates

Future events
There are no future events available.
Past events
Quarter 3 results 15 June 2021 15/06/21
Interim results 02 March 2021 02/03/21
Quarter 2 results 02 March 2021 02/03/21
AGM 07 December 2020 07/12/20
Quarterly results 25 November 2020 25/11/20
Annual report 02 November 2020 02/11/20
Final results 27 October 2020 27/10/20

General stock information

EPIC:
RENX
ISIN:
GB00BYWL4Y04
Market cap:
£516.52 million
Shares in issue:
72.24 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE AIM 100,FTSE AIM All Share

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.